兗州煤業股份(01171.HK)及山東能源增資兗礦財務
兗州煤業股份(01171.HK)公布,董事會批准公司與山東能源集團、兗礦財務公司簽署增資協議,公司對兗礦財務公司的持股比例為95%,山東能源對兗礦財務公司的持股比例為5%。根據增資協議,公司與山東能源按各自於公告披露日的持股比例以現金方式向兗礦財務公司增資。
本次增資以兗礦財務公司最近一期經審計淨資產值為基礎確定增資價格,即公司出資19.11億元人民幣(下同),其中14.25億元計入註冊資本金,剩餘款項計入資本公積;山東能源出資1億元,其中7,500萬元計入註冊資本金,剩餘款項計入資本公積。增資完成後,兗礦財務公司註冊資本金由25億元增加至40
億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.